Detalhe da pesquisa
1.
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment.
Gene Ther
; 24(2): 92-103, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27906162
2.
Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients.
Int Immunopharmacol
; 90: 107226, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33316742
3.
Kick-starting the cancer-immunity cycle by targeting CD40.
Oncoimmunology
; 4(7): e1011484, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26140231
4.
CD40L gene therapy tilts the myeloid cell profile and promotes infiltration of activated T lymphocytes.
Cancer Gene Ther
; 21(3): 95-102, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24481488
5.
Resolvin E1 reduces proinflammatory markers in human pancreatic islets in vitro.
Exp Clin Endocrinol Diabetes
; 118(4): 237-44, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20119897